Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Peter Zeihan: Europe Goes Nuclear
We’ve got two major developments in Eurasia. We’re talking about Ukraine disabling two ships in the Caspian Sea and Poland getting EU approval to build…
Thought Leader: Peter Zeihan
Dr. Sanjay Gupta’s Top Health Stories of 2025
From the resurgence of measles to a new way to treat pain, 2025 was a challenge for public health while still offering moments of hope. Sanjay…
Thought Leader: Sanjay Gupta
Ian Bremmer: The state of global conflict in 2025
On GZERO World, Ian Bremmer takes a hard look at the biggest global crises and conflicts that defined our world in 2025 with CNN’s Clarissa…
Thought Leader: Ian Bremmer